Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03455829
Title G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors G1 Therapeutics, Inc.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Beverly Hills Cancer Center Beverly Hills California 90211 United States Details
UCLA Medical Center, Division of Hematology/Oncology/Clinical Research Unit Santa Monica California 90404 United States Details
St Joseph Heritage Healthcare Santa Rosa California 95403 United States Details
Sylvester Comprehensive Cancer Center/University of Miami Miller School of Medicine Fox Building, Suite 200 G Miami Florida 33136 United States Details
Mofitt Cancer Center Tampa Florida 33612 United States Details
Univ. of Michigan Hospitals Ann Arbor Michigan 48109 United States Details
Virginia Cancer Specialists Fairfax Virginia 22301 United States Details
Froedtert Hospital & the Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from for the field